We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 518

Let's talk about the HHS "conscience" protections for healthcare employees
  • Constangy Brooks Smith & Prophete LLP
  • USA
  • January 19 2018

Here's what employers need to know. Yesterday, the U.S. Department of Health and Human Services and its Office of Civil Rights announced that they

CMS Approves West Virginia’s Substance Use Disorder Waiver
  • Manatt Phelps & Phillips LLP
  • USA
  • October 26 2017

On October 6, the Centers for Medicare & Medicaid Services (CMS) approved West Virginia's "Creating a Continuum of Care for Medicaid Enrollees with

Trump Administration Limits Affordable Care Act’s Contraceptive Coverage Mandate
  • Epstein Becker Green
  • USA
  • October 12 2017

On Friday October 6, 2017, the Trump administration released two interim final rules expanding the exemptions allowed under the Patient Protection

Federal Agencies Announce Plan B for the Contraceptives Mandate
  • Bradley Arant Boult Cummings LLP
  • USA
  • October 9 2017

The triumvirate of federal agencies (HHS, DOL, IRS) responsible for enforcing the Patient Protection and Affordable Care Act (the ACA, often called

Uncertainty Becomes the Normfor 340B Rulemaking, at Least
  • Arent Fox LLP
  • USA
  • August 29 2017

On August 21, 2017, the Health Resources and Services Administration (HRSA) published a proposed rule (the Proposed Rule) that would entertain even

Iowa Submits Sweeping 1332 Waiver Seeking Emergency Relief
  • Manatt Phelps & Phillips LLP
  • USA
  • June 21 2017

On June 12, Iowa submitted a sweeping Section 1332 waiver that would replace the Affordable Care Act’s (ACA) premium tax credits with a new

Overtime Rule Update: DOL To File Request for Information In Two to Three Weeks
  • Hunton Andrews Kurth LLP
  • USA
  • June 9 2017

One of the most controversial regulatory actions from the US Department of Labor during the Obama administration was the DOL’s regulation

Price, Verma Taking a Fresh Look at Obama Administration’s EPMCJR Final Rule; Changes Pushed Back to at Least October 1, 2017
  • Reed Smith LLP
  • USA
  • March 21 2017

HHS Secretary Thomas Price and CMS Administrator Seema Verma have signaled that the Trump Administration is eyeing changes to one of the last major

To Congress, President Trump Addresses Affordable Care Act, Prescription Drug Costs and Food and Drug Administration
  • Sidley Austin LLP
  • USA
  • March 15 2017

On Feb. 28, President Donald Trump outlined his administration's policy priorities during his first address to Congress. Among the topics he

Bundles, MACRA and the Trump Regulatory Freeze
  • Baker & Hostetler LLP
  • USA
  • March 7 2017

In the final months of the Obama administration, CMS released rules of significant import to healthcare providers, including a final rule explaining